IPC to host 37th Skill Development Programme on Pharmacovigilance from June 15-19, 2026
The Indian Pharmacopoeia Commission (IPC), functioning as the National Coordination Centre for the Pharmacovigilance Programme of India (PvPI), has announced the 37th Skill Development Programme (SDP) on Pharmacovigilance.
Scheduled for June 2026, this intensive training is designed to enhance the technical expertise of professionals and students in monitoring drug safety and managing adverse drug reactions (ADRs).
Below is a detailed summary of the proposed program :
Advancing Drug Safety: IPC Announces 37th Skill Development Programme on Pharmacovigilance
In an effort to further strengthen the pharmacovigilance ecosystem in India, the Indian Pharmacopoeia Commission (IPC) is inviting applications for its upcoming 37th Skill Development Programme. As the WHO Collaborating Centre for Pharmacovigilance in Public Health Programmes and Regulatory Services, the IPC continues to play a pivotal role in ensuring that the benefits of pharmaceutical products outweigh their risks.
Program Overview
Pharmacovigilance (PV) is the cornerstone of patient safety, involving the detection, assessment, and prevention of adverse effects. This five-day professional training program offers a deep dive into both the theoretical frameworks and practical applications of PV, aligned with national and global standards.
- Dates: June 15 – 19, 2026
- Mode: Offline / Classroom-based (Physical attendance required)
- Location: Indian Pharmacopoeia Commission (IPC), Ghaziabad
Session Objectives
The training is structured to provide participants with a comprehensive understanding of the PV lifecycle. Key objectives include:
- Fundamental Principles: Mastering the basics of PV and the current regulatory landscape in India.
- ADR Reporting: Developing practical skills for the identification, documentation, and reporting of Adverse Drug Reactions (ADRs).
- Risk Management: Learning effective risk assessment strategies and signal detection techniques.
- Regulatory Compliance: Understanding IPC and global regulatory requirements to ensure organizational compliance.
- Networking: Facilitating collaboration between healthcare professionals, industry stakeholders, and regulatory authorities.
Target Audience & Eligibility
This program is highly recommended for stakeholders committed to enhancing clinical safety and regulatory excellence, including:
- Students of Pharmacy (B.Pharm/M.Pharm), Pharm.D, MBBS, BDS, and Nursing.
- Young professionals and practitioners currently working in Pharmacovigilance.
- Academicians, Researchers, and Industry Professionals.
- Pharmacists, Nurses, and Doctors in clinical practice.
- Representatives from NGOs and consumer healthcare groups.
Registration & Fee Details
Due to the interactive nature of the classroom mode, seats are limited. Early registration is encouraged to ensure participation.
How to Register:
Applications can be submitted by scanning the official QR code provided by the IPC or visiting their portal.
Registration Fee:
₹10,000 (including GST)
Registration Deadline:
June 8, 2026
Why Should You Register?
For consulting organizations and healthcare entities, this SDP represents a critical opportunity to upskill teams in alignment with the latest Ministry of Health and Family Welfare guidelines. By participating, you contribute to the national goal of indigenous safety monitoring and public health resilience.
How to Apply:
Applications are now open. Prospective participants are urged to register early to secure their place in this prestigious program. Detailed application forms and payment links can be found on the Official IPC Website.
Contact Information: For any queries, stakeholders may reach out to the IPC at:
- Phone: 0120-2783400 Ext. 374, 378
- Email: training.nccpvpi-ipc@gov.in
- Website: http://www.ipc.gov.in